Similar Posts
Zydus Life Gets USFDA Nod for Eluxadoline Tablets, Shares Up 1.5% – Equitypandit
March 17, 2025March 17, 2025 Shares of Zydus Lifesciences Ltd rose 1.5% to touch a day’s high of Rs 901.30 on 17th March after the firm announced that it had received final approval from the US Food and Drug Administration (USFDA) to manufacture Eluxadoline Tablets,…
23andMe cuts 40% of its workforce, discontinues all therapy programs By Reuters
(Reuters) -Genetic testing firm 23andMe said on Monday it is reducing about 40%, or 200 employees, from its workforce and discontinuing further development of all its therapies as part of a restructuring program. “We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core consumer…
USD/CAD Steady at 1.3726 as Markets Eye Economic Reports
USD/CAD Steady at 1.3726 as Markets Eye Economic Reports Home Forex USD/CAD Steady at 1.3726 as Markets Eye Economic Reports Source link
Who is the greatest trader of all time?
Part 1 http://www.traderdaily.com/magazine/article/2598.html Registrations is free to the site above. The list below from the article may be of interest. Here is first part of the article for those who do not have a sign-in: Trader Monthly 100: The Top 10 The highest-earning traders of 2005. By: Rich Blake , A.D. Barber , Robert LaFranco …
The Alchemy of Deceit: Wall Street Discovers the Debasement Trade, Math and Gravity The Debasement Trade
Once upon a time, alchemists sought to turn lead into gold. Today’s Wall Street has perfected a more lucrative trick: turning inflation into profit. What medieval mystics pursued through fire and faith, modern financiers accomplish with leverage, derivatives, and enough financial engineering to make Rube Goldberg blush. This isn’t a story about hidden laboratories or…
Monday’s Movers, 4 New Potential Targets
Good Beginning to the Trading Week: We put our best foot forward yesterday despite having no big time earnings reports off of which to base the ideas in our premarket report. We still managed to unearth some solid movers, and the rest of the week should look pretty good in terms of the earnings reports coming…